HaploX Biotechnology Employee Directory
Biotechnology ResearchGuangdong, China11-50 Employees
HaploX Biotechnology is a Shenzhen-based company in the biotechnology research field focused on improving cancer patient management through an integrated approach that combines liquid biopsy, sequencing, artificial intelligence, and big data. Its core capabilities involve capturing circulating tumor DNA from liquid samples, enriching ultra-low amounts of DNA, performing targeted sequencing, and organizing and interpreting the resulting data for clinical and research use. The company serves cancer care providers and research institutions seeking to advance precision oncology through sophisticated data-driven insights. Founded in 2014, HaploX operates a polycentric global footprint that includes an R&D headquarters in Shenzhen, a US R&D center, a GMP manufacturing facility, a third-party medical laboratory, and the ShangRao International Precision Medical Health Industrial Park. In December 2023, HaploX announced a collaboration with Illumina to develop a domestically produced flagship benchtop sequencing system. The firm has also participated in European Molecular Genetics Quality Network external quality assessment schemes, achieving satisfactory results in lung cancer and oncogene panel testing.